Bogle Investment Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-75,409
Closed -$951K – 352
2018
Q4
$951K Buy
+75,409
New +$1.12M 0.07% 216
2015
Q1
– Sell
-137,285
Closed -$572K – 392
2014
Q4
$572K Sell
137,285
-68,017
-33% -$313K 0.04% 292
2014
Q3
$1.07M Buy
+205,302
New +$1.05M 0.07% 242

Other funds holding NEO

Bogle Investment Management's NEO Position: Q1 2019 in Review

Bogle Investment Management sold out of NeoGenomics (NEO) in Q1 2019, closing a stake of 75,409 shares — an estimated $951K sold.

Bogle Investment Management first reported a position in NEO in Q3 2014 and held it in 3 quarters. The position peaked at $1.07M in Q3 2014. 235 funds tracked by Wall St. Rank hold NEO as of Q1 2019.

  • Bogle Investment Management reported no remaining NeoGenomics position as of Q1 2019 after selling out during the quarter.
  • Bogle Investment Management sold 75,409 NeoGenomics shares in Q1 2019, an estimated $951K.
  • Bogle Investment Management first reported a position in NeoGenomics in Q3 2014 and held it in 3 quarters.
  • Bogle Investment Management's NeoGenomics position peaked at $1.07M in Q3 2014.
  • 235 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2019.

Based on Bogle Investment Management's 13F filing for Q1 2019, filed 13 May 2019.